#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Adrenocortical carcinoma Vaginal cancer Thrombotic microangiopathy Retinoblastoma Plasma cell myeloma Hypergammaglobulinaemia benign monoclonal Optic glioma Small cell lung cancer limited stage Bile acid synthesis disorder Metastases to peritoneum Neuroendocrine carcinoma metastatic Cardiac arrest Follicle centre lymphoma follicular grade I, II – III Atopic keratoconjunctivitis Rectal cancer More trials…

    Learn about Rare Diseases

    Undifferentiated sarcoma – Basic Information Angiosarcoma metastatic – Life with Disease Combined immunodeficiency – Treatment Angiosarcoma metastatic Chondrosarcoma – Basic Information Waldenstrom’s macroglobulinaemia recurrent – Treatment Osteosarcoma metastatic – Life with Disease Progressive multifocal leukoencephalopathy – Diagnostics Noonan syndrome – Life with Disease Hereditary angioedema with C1 esterase inhibitor deficiency More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Amitriptyline Ceralasertib Tocotrienol Bms-986442 Trospium Chloride Tetracaine Hydrochloride Sotalol Gs-5245 Rbp030.2 Safinamide Levofloxacin Hemihydrate Fluorouracil Azelastine Migalastat Midodrine Hydrochloride Gadoquatrane Saruparib Atl001 Dirocaftor Tanimilast More therapies…

    Learn about Your Condition

    Left ventricular failure Colorectal cancer MELAS syndrome Fibrosarcoma Chronic lymphocytic leukaemia Glaucoma Thyroid cancer Naevus flammeus Oral neoplasm Ventricular fibrillation Status epilepticus Tumour of ampulla of Vater Dystonia Atrial fibrillation Cutaneous sarcoidosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Istituto Oncologico Veneto

Istituto Oncologico Veneto

Via Gattamelata 64, Padua, 35128, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Safety and Effectiveness of Osimertinib and Datopotamab Deruxtecan for Patients with Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Datopotamab Deruxtecan
    • Osimertinib
    France Germany Italy Poland Spain

  • Study on APL-101 for Treating Advanced Solid Tumors and Non-Small Cell Lung Cancer with MET Changes in Patients

    Recruiting

    1 1 1
    Investigated Diseases:
    • Central nervous system neoplasm
    • Neoplasm
    • Non-small cell lung cancer
    Investigated Drugs:
    • Apl-101
    France Hungary Italy Spain

  • Study of Ibrutinib for Treating Autoimmune Hemolytic Anemia in Patients with Chronic Lymphocytic Leukemia or Similar Conditions

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Ibrutinib
    Italy

  • Study of Azacitidine and Drug Combination Before Stem Cell Transplantation in Patients with High-Risk Myelodysplastic Syndrome

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Daunorubicin Hydrochloride
    • Cytarabine
    • Thiotepa
    Italy

  • Study on Preoperative Chemoradiotherapy with Capecitabine and Temozolomide for Patients with Locally Advanced Rectal Cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Temozolomide
    • Capecitabine
    Italy

  • Study of Atezolizumab with Drug Combination for Patients with Unresectable Metastatic Colorectal Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Atezolizumab
    • Bevacizumab
    • Calcium Folinate
    Italy

  • Study of tazemetostat combined with lenalidomide and rituximab in adult patients with relapsed or refractory follicular lymphoma

    Recruiting

    3 1 1
    Investigated Diseases:
    • Follicular lymphoma
    Investigated Drugs:
    • Tazemetostat
    • Lenalidomide
    • Rituximab
    Belgium France Germany Hungary Italy Poland +1

  • Study on Zanidatamab with Cisplatin and Gemcitabine for Advanced HER2 Positive Biliary Tract Cancer Patients

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Zanidatamab
    • Cisplatin
    • Durvalumab
    Belgium Czechia Finland France Germany Italy +4

  • Study for Patients with BRCA Mutated Ovarian, Breast, Pancreatic, Prostate, and Endometrial Cancers Continuing Olaparib Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Prostate cancer
    • Pancreatic carcinoma metastatic
    • Breast cancer
    Investigated Drugs:
    • Olaparib
    Belgium Bulgaria Czechia France Germany Hungary +6

  • Study on the Safety of Encorafenib, Binimetinib, and Ribociclib for Patients with Solid Tumors

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Neoplasm
    • Neoplasm malignant
    Investigated Drugs:
    • Vemurafenib
    • Binimetinib
    • Encorafenib
    Czechia France Germany Greece Hungary Italy +4
Previous Page
1 … 9 10 11 12 13 … 42
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!